anti-PCSK9

PCSK9 inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for anti-PCSK9, covering 2024-01-30 to 2024-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia [Phase 4]